CN100506227C - 含有(r)-3-[(s)-(5-氧-2-吡咯烷基)羰基]-噻唑烷-4-羧基的滴丸剂型及其制备方法 - Google Patents
含有(r)-3-[(s)-(5-氧-2-吡咯烷基)羰基]-噻唑烷-4-羧基的滴丸剂型及其制备方法 Download PDFInfo
- Publication number
- CN100506227C CN100506227C CNB2005100410632A CN200510041063A CN100506227C CN 100506227 C CN100506227 C CN 100506227C CN B2005100410632 A CNB2005100410632 A CN B2005100410632A CN 200510041063 A CN200510041063 A CN 200510041063A CN 100506227 C CN100506227 C CN 100506227C
- Authority
- CN
- China
- Prior art keywords
- carboxyl
- thiazolidine
- pyrrolidinyl
- carbonyl
- oxygen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100410632A CN100506227C (zh) | 2005-07-15 | 2005-07-15 | 含有(r)-3-[(s)-(5-氧-2-吡咯烷基)羰基]-噻唑烷-4-羧基的滴丸剂型及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100410632A CN100506227C (zh) | 2005-07-15 | 2005-07-15 | 含有(r)-3-[(s)-(5-氧-2-吡咯烷基)羰基]-噻唑烷-4-羧基的滴丸剂型及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1723894A CN1723894A (zh) | 2006-01-25 |
CN100506227C true CN100506227C (zh) | 2009-07-01 |
Family
ID=35923609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100410632A Active CN100506227C (zh) | 2005-07-15 | 2005-07-15 | 含有(r)-3-[(s)-(5-氧-2-吡咯烷基)羰基]-噻唑烷-4-羧基的滴丸剂型及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100506227C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102167727B (zh) * | 2011-01-29 | 2013-05-15 | 浙江金立源药业有限公司 | 一种匹多莫德的合成方法 |
-
2005
- 2005-07-15 CN CNB2005100410632A patent/CN100506227C/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN1723894A (zh) | 2006-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5377465B2 (ja) | 治療剤製品、その使用及び製剤形態 | |
MX2010014566A (es) | Proceso de granulacion de fundido. | |
CN1970547A (zh) | 非布司他的新晶型及其制备方法 | |
CA2366841C (en) | Tolperisone-containing pharmaceutical preparation for oral administration | |
AU2018256998B2 (en) | Pharmaceutical composition for oral administration comprising | |
US7666860B2 (en) | Melt-formulated, multi-particulate oral dosage form | |
JP2004525887A (ja) | 新規フェノフィブラート錠剤 | |
CN108285431B (zh) | 一种吡非尼酮有关物质及其制备方法和用途 | |
KR20110007255A (ko) | 고형 의약 제제 | |
CN100506227C (zh) | 含有(r)-3-[(s)-(5-氧-2-吡咯烷基)羰基]-噻唑烷-4-羧基的滴丸剂型及其制备方法 | |
CA2397942C (en) | Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation | |
JP2001503734A (ja) | カリウム、ナトリウムおよびトリスオキサプロジン塩医薬組成物 | |
CN105534929A (zh) | 曲格列汀药物组合物 | |
CN101889989A (zh) | 一种阿莫西林肠溶缓释制剂组合物及其制备方法 | |
EP2175855B1 (en) | Stable pharmaceutical composition of a water-soluble vinorelbine salt | |
CN105412132A (zh) | 复方伊维菌素缓释颗粒剂及其制备方法 | |
CN102048738A (zh) | 含有环嘧耐平药用复合物的药物组合物制剂 | |
CN109464409A (zh) | 一种美沙拉秦口服缓控释制剂 | |
JP6461496B2 (ja) | 解熱鎮痛製剤 | |
CN112972395B (zh) | 胶囊制剂及其制备方法和应用 | |
CN108514550A (zh) | 含有醋酸阿比特龙的固体药物及其制备方法 | |
CN102247369B (zh) | 复方萘普生埃索美拉唑药物组合物及其制备方法 | |
RU2525433C2 (ru) | Лекарственный препарат винкамина в форме матричных таблеток для улучшения мозгового кровообращения и способ его изготовления | |
CN103142565B (zh) | 一种尼美舒利的缓释药物组合物及其制备方法 | |
CN100528203C (zh) | 龙血竭滴丸及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU WUZHONG PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER OWNER: CHANGZHENG-XINKAI PHARMACEUTIC CO., LTD., SUZHOU Effective date: 20130808 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130808 Address after: Soochow road 215128 in Jiangsu Province, Suzhou Wuzhong Economic Development Zone No. 2 Building 8 Patentee after: Jiangsu Wuzhong Medical Group Co.,Ltd. Address before: 215128 No. 2, Soochow South Road, Jiangsu, Suzhou Patentee before: Changzheng-Xinkai Pharmaceutical Co., Ltd., Suzhou |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161026 Address after: Soochow road 215128 in Jiangsu Province, Suzhou Wuzhong Economic Development Zone No. 2 Building 8 Patentee after: Jiangsu Wuzhong Medical Group Co.,Ltd. Patentee after: Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Suzhou pharmaceutical factory Address before: Soochow road 215128 in Jiangsu Province, Suzhou Wuzhong Economic Development Zone No. 2 Building 8 Patentee before: Jiangsu Wuzhong Medical Group Co.,Ltd. |